HealthTech startup ecosystem
European healthtech startups are transforming care delivery, diagnostics, and drug discovery. Strong public health systems create natural testing grounds, while regulatory clarity through CE marking and the MDR framework gives European companies a path to scale. We track 215 organisations in this sector across 6+ countries.
Showing 141–160 of 215HealthTech
Countries in this sector
Sectors alongside this one
HealthTech results
Natural Cycles
Natural Cycles is a Stockholm-based femtech company founded in 2013 that makes a fertility-awareness app which uses body-temperature data and an algorithm to identify fertile and non-fertile days. It became the first app cleared by the US FDA to be marketed as a form of contraception and also supports users planning pregnancy.
Neko Health
Neko Health is a Stockholm-based preventive health company co-founded in 2018 by Hjalmar Nilsonne and Daniel Ek (the Spotify founder). Neko operates clinics that offer AI-powered full-body health scans using proprietary sensors and imaging technology to detect early signs of cardiovascular disease, skin cancer, diabetes, and other conditions. A scan takes about 15 minutes and costs a fraction of traditional medical imaging. The company has raised over $260 million, including a $260 million round in 2024, and is expanding its clinic network across Sweden and the UK. Neko Health represents a new model of proactive, technology-driven healthcare that could reshape how Europeans approach preventive medicine.
Neuraccure
Monaco digital health company in the MonacoTech portfolio, building iPad applications for advanced neurological examination. Its Vision tool handles video oculography and Synapse runs multidimensional neurological testing, together aimed at detecting subtle abnormalities at preclinical stages that a conventional bedside examination would miss.
Neurent Medical
Neurent Medical is a Galway-based medtech company developing the NEUROMARK device, which uses proprietary Impedance Controlled Radiofrequency technology to target overactive posterior nasal nerves and treat chronic rhinitis — a condition affecting over 500 million people globally. Founded in 2015, the company closed an oversubscribed €62.5 million Series C in February 2026, led by MVM Partners with participation from Sofinnova Partners, EQT Life Sciences, Atlantic Bridge, and Enterprise Ireland, bringing total funding to over €100 million.
Neurobalance
Andorra la Vella clinic on the national innovative-companies map under health and biotech, working in non-invasive neuromodulation. It applies low-frequency microcurrents to stimulate the autonomic nervous system for sleep disorders, stress and emotional regulation, combining neuromodulation with biofeedback, physiotherapy, nutrition and coaching in personalised plans.
Neuromedical
Polish-Israeli medtech startup developing VGuard, a non-invasive vagus nerve stimulation system aimed at improving cognitive outcomes in patients with Alzheimer’s disease and dementia. The company is advancing clinical validation and regulatory pathways across Europe and the US.
Neuromod Devices
Medical-device company developing bimodal neuromodulation technology. Its flagship product Lenire is the first FDA-approved bimodal neuromodulation tinnitus treatment, available in 130+ clinics across the US and Europe. Founded 2010.
Nightingale Health
Nightingale Health is the global leader in NMR-based metabolomics, quantifying 250 blood biomarkers from a single sample to enable large-scale disease risk detection and prevention. Founded in Helsinki, it completed the analysis of all 500,000 UK Biobank samples, creating the world's largest blood biomarker database. Listed on Nasdaq Helsinki Main Market since March 2025, the company is deploying its technology into Finnish public healthcare in 2026 through wellbeing services counties. It also partnered with Alamar Biosciences to expand into brain health proteomics.
No Isolation
No Isolation is a Norwegian scale-up founded in 2015 that develops telepresence robots to combat social isolation. Its flagship product, the AV1 robot, serves as a physical avatar in classrooms for children with long-term illness or special education needs, keeping them connected to school and peers when they cannot attend. The company now serves over 900 customers across 19 countries with more than 3,000 AV1 units deployed in around 2,500 schools, supporting over 10,000 children. No Isolation won the 2025 EURORDIS Company Award for Health Technology.
Nobi
Nobi makes AI-powered smart ceiling lamps for senior living facilities that detect falls within seconds, alert caregivers instantly and monitor sleep, activity and circadian patterns to prevent incidents. Its model was trained on 250,000+ real-life fall scenarios; in clinical studies across five care homes, Nobi reduced average caregiver response time from over one hour to four minutes and cut falls by 51%. Founded in 2018 in Antwerp by Roeland Pelgrims, Bert De Haes and Stijn Verrept, it closed a €35 M Series B (co-led by Angelini Ventures and Nexus NeuroTech) in January 2025. Nobi is deployed in 22 countries with offices in Belgium, the US and the UK.
Nordic Life Science Days 2026
The premier Nordic life-science partnering event organised by SwedenBIO, rotating to Stockholm in 2026. Brings biotech, pharma, medtech, and digital-health players together for partnering meetings, panels, and company presentations.
Nucleus Ventures
Nucleus Ventures is a venture building and corporate innovation advisory firm based in Cyprus, founded in 2014. It offers services including venture building, fundraising, soft-landing support for international market entry, operational advisory, and capacity building programmes. The firm serves governments, corporations, and founders across the EMENA region, with particular experience in FinTech, HealthTech, and AI. Nucleus Ventures has also managed government-backed accelerator and seed fund programmes.
Nutrium
Nutrium is a Portuguese nutrition-practice software company that builds tools for dietitians and nutrition professionals to manage client care. Its platform pairs a practice-management system for dietitians with a consumer app, and its Nutrium Care product is sold to companies and health plans as an employee nutrition benefit combining technology, dietitians and corporate workshops. The company serves clients internationally alongside its home market of Portugal.
Omixon
Molecular diagnostics company developing next-generation sequencing assays and software for HLA typing in transplantation, including the Holotype HLA and NanoTYPE systems for clinical labs.
Oslo Innovation Week 2026
Norway's largest innovation festival spanning a full week with 100+ events across Oslo, organized by Innovation Norway and the City of Oslo. Covers cleantech, ocean tech, healthtech, and fintech with 10,000+ participants. Most events are free or low-cost, making it highly accessible.
Oura
Oura is a Finnish wearable company best known for the Oura Ring, a smart ring that packages continuous biometric sensing into a minimal consumer device. The product built its reputation through strong sleep and recovery tracking, then expanded into broader health insights around readiness, activity, stress, and women's health. What makes Oura significant in the European ecosystem is its ability to combine hardware design, sensor engineering, mobile product experience, and recurring software engagement into a durable health platform. Many consumer wearables compete on notifications and surface-level metrics; Oura instead positioned itself around insight quality, habit formation, and long-term user retention. That has made it a standout European example of a hardware-plus-subscription business that can scale globally without losing product clarity. In directory terms, Oura also broadens the map between consumer technology and healthtech, showing how European startups can build defensible products at the intersection of devices, data, and preventive care. Its success offers a useful contrast to pure software companies and highlights Finland's continued ability to produce globally relevant product and hardware talent.
Oviva
Oviva is a digital health company that helps people with weight-related and metabolic conditions, including obesity, type 2 diabetes, prediabetes, and hypertension, improve their health through medical nutritional therapy. Its model combines a medical-device-certified smartphone app with clinical teams of doctors, dietitians, and behavioural specialists, with patients logging meals, activity, and weight while receiving tailored remote support from their dietitian. The company describes itself as Europe's leading digital health provider for weight-related conditions, with care reimbursed as a certified DiGA in Germany, delivered in partnership with the NHS in the UK, and integrated into Swiss public healthcare. It is headquartered in Zurich.
Panakès Partners
Founded in 2015, Panakes Partners is a Milan-based healthcare VC investing EUR 1-8M at Series A and B in medical devices, diagnostics, digital health, and biotech across Europe. The firm manages over EUR 100M and focuses on companies with clear clinical evidence and regulatory pathways. Portfolio includes MMI (surgical robotics, IPO on Euronext), Novavido, and Kither Biotech. The team of medtech executives and clinicians provides hands-on support in clinical trials, CE marking, and commercialization.
Patronus Group
Berlin-based healthtech company offering an emergency smartwatch paired with a companion app for elderly people living independently. The SIM-enabled device connects to a 24/7 emergency call centre at the press of a button and keeps family members informed. Serves 25,000 users and has handled over 500,000 emergency calls.
Pixacare
Pixacare is a Strasbourg-based medtech company providing a medical photography and wound-care platform used by hospitals to document, measure, and remotely monitor chronic, post-surgical, and dermatological wounds. Its WoundTrack-II module is a CE-marked Class IIa AI medical device that automatically measures wound surface area and tissue composition from photographs, while the core app carries a CE Class I marking. The platform is used by more than 50 hospitals and clinics, has documented over 1 million lesions for more than 200,000 patients, and reports clinical studies showing reduced healing time and fewer in-person consultations with remote wound monitoring.
